Despite being a late entrant in the market, Emcure has leapfrogged its peers and established itself as a leading player with a niche product basket and positioning. Emcure achieved a major milestone in April 2021 as it was ranked as the 9th largest company in the Indian pharma market (AICOD-AWACS April-21).
The product basket of Emcure Pharmaceuticals which has a strong chronic and sub-chronic focus, covers all the major therapies and is the market leader in areas such as women's health, blood-related, HIV, anti-infectives, cardiac and vitamins.
Industry leader addressing women’s health issues
Pioneers in Chirality
Leaders in the global fight against HIV
Chirally Pure Brand
Strong Biologics Portfolio
Emerging player in this fight against chronic condition
Largest portfolio with best-in-class medicines
Differentiated portfolio aiding growth
Bringing innovation for stroke